Teva(TEVJF)
Focus: Teva is a global pharmaceutical leader headquartered in Israel with a diversified portfolio spanning small molecules and biologics across neurology, cardiovascular, oncology, infectious diseases, and immunology. The company generates ~$15B in annual revenue with significant exposure to both branded and generic products.
Profile data last refreshed 9h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
Recent layoff filing — 205 affected
- 11/18/2025 — Salt Lake City, UT · 205 affected · Layoff Amendment
Source: state DOL filings via Big Local News
About Teva
AI assessmentNot HiringNo open roles listed right now. Follow Teva to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Teva's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
8 imminent
ADASUVE
Hiring
Stable
Revenue
$1.5B
FY2025
Key Products
$1.1B Part DStable
Peak12.0yr
Flagship product generating 35% of company revenue with extended patent protection; core to financial stability and justification for high R&D spend.
Help build intelligence for Teva
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.